Company profile: Seismic Therapeutic
1.1 - Company Overview
Company description
- Provider of machine-learning technology for immunology drug development, offering the IMPACT platform to accelerate novel biologics by integrating machine learning with structural biology, protein engineering, and translational immunology; Ig Sculpting Enzymes to modify pathogenic antibodies in autoimmune diseases, optimized for reduced immunogenicity while retaining enzyme activity; and Dual-cell Bidirectional antibodies engaging multiple inhibitory pathways in immune cells to restore immune homeostasis.
Products and services
- IMPACT Platform: A scalable machine learning platform that accelerates generation of novel biologics by integrating structural biology, protein engineering, and translational immunology
- Dual-cell Bidirectional (DcB) Antibodies: Custom-engineered antibodies designed to engage multiple inhibitory pathways in immune cells, aiming to restore immune homeostasis in autoimmune diseases
- Ig Sculpting Enzymes: Therapeutic-grade enzymes developed to modify pathogenic antibodies for treating autoimmune diseases, optimized to reduce immunogenicity while preserving enzyme activity
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Seismic Therapeutic
Frontier Medicines
HQ: United States
Website
- Description: Provider of a biopharmaceutical drug discovery platform integrating chemoproteomics, covalent chemistry, and machine learning to accelerate medicine development; programs include a dual KRASG12C inhibitor (FMC-376) targeting active and inactive forms in cancers and AutoTAC for autophagy-driven targeted degradation; tools span ML/AI prioritization, chemoproteomics to identify druggable hotspots, and a covalent fragment library.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Frontier Medicines company profile →
Wolflabs
HQ: United Kingdom
Website
- Description: Provider of laboratory equipment via a predominantly web-based platform, offering immediate access to market-priced product information and value for money.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Wolflabs company profile →
Complion
HQ: United States
Website
- Description: Provider of an eRegulatory digital platform for clinical research sites, enabling administrators and research coordinators to more efficiently maintain compliance protocols, supporting investigators with fewer hassles, and streamlining crucial information for auditors and quality assurance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Complion company profile →
Cryoport
HQ: United States
Website
- Description: Provider of outsourced temperature-controlled shipping and logistics for biological materials, offering ISO 21973-compliant shipping systems across cryogenic, ultra-cold (dry ice), refrigerated and controlled room temperatures; IntegriCell cryopreservation; integrated BioServices and biostorage; consulting to de-risk biologics and cell & gene therapy supply chains; and comprehensive upstream/downstream supply chain management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cryoport company profile →
BBK Worldwide
HQ: United States
Website
- Description: Provider of patient recruitment marketing and clinical trial support for the pharmaceutical, biotechnology, and medical device industries, offering strategy and research for trial enrollment, creative recruitment campaigns, targeted outreach across media channels, apps, and influencers, site success services (prescreening, referral management, communications), participant travel logistics with concierge support, and global participant payment reimbursement with instant access to funds.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BBK Worldwide company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Seismic Therapeutic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Seismic Therapeutic
2.2 - Growth funds investing in similar companies to Seismic Therapeutic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Seismic Therapeutic
4.2 - Public trading comparable groups for Seismic Therapeutic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →